Bart J. L. Eggen

Bart J. L. Eggen

Auto-generated profile, based on publicly available information

Bart J. L. Eggen

Department of Biomedical Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2015 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
IHInge R Holtman
Inge R Holtman
DRDivya D A Raj
Divya D A Raj
JMJeremy A Miller
Jeremy A Miller
WSWandert Schaafsma
Wandert Schaafsma
ZYZhuoran Yin
Zhuoran Yin
BEBart J L Eggen
Bart J L Eggen
Microglia are tissue macrophages of the central nervous system that monitor brain homeostasis and react upon neuronal damage and stress. Aging and neurodegeneration induce a hypersensitive, pro-inflammatory phenotype, referred to as primed microglia. To determine the gene expression signature of priming, the transcriptomes of microglia in aging, Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) mouse models were compared using Weighted Gene Co-expression Network Analysis (WGCNA). A highly consistent consensus transcriptional profile of up-regulated genes was identified, which prominently differed from the acute inflammatory gene network induced by lipopolysaccharide (LPS). Where the acute inflammatory network was significantly enriched for NF-κB signaling, the primed microglia profile contained key features related to phagosome, lysosome, antigen presentation, and AD signaling. In addition, specific signatures for aging, AD, and ALS were identified. Microglia priming induces a highly conserved transcriptional signature with aging- and disease-specific aspects.

1 July 2017 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZYZhuoran Yin
Zhuoran Yin
DRDivya Raj
Divya Raj
NSNasrin Saiepour
Nasrin Saiepour
DDDebby Van Dam
Debby Van Dam
NBNieske Brouwer
Nieske Brouwer
EBErik Boddeke
Erik Boddeke

25 September 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
ZYZhuoran Yin
Zhuoran Yin
NRNeta Rosenzweig
Neta Rosenzweig
KKKilian L. Kleemann
Kilian L. Kleemann
XZXiaoming Zhang
Xiaoming Zhang
WBWesley Brandão
Wesley Brandão
OBOleg Butovsky
Oleg Butovsky

31 July 2020 in Science
Verified
Journal Article
Closed access
LKL. Kracht
L. Kracht
MBM. Borggrewe
M. Borggrewe
SES. Eskandar
S. Eskandar
NBN. Brouwer
N. Brouwer
SLSusana Chuva De Sousa Lopes
Susana Chuva De Sousa Lopes
BEB. J. L. Eggen
B. J. L. Eggen
The development of microglia: Microglia are the brain's immune cells, and they play important roles in health and neurodegenerative disease. Kracht et al. performed single-cell analysis of human microglial gene expression and chromatin accessibility and compared the results with those of other studies of human and mice microglial development. By using in situ validation, these data identify fetal microglial subsets that appear to be distinct from adult human microglia, suggesting functional differences between the developing and mature brain. Science , this issue p. 530

13 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAngélica María Sabogal-Guáqueta
Angélica María Sabogal-Guáqueta
AMAlejandro Marmolejo-Garza
Alejandro Marmolejo-Garza
MTMarina Trombetta-Lima
Marina Trombetta-Lima
AOAsmaa Oun
Asmaa Oun
JHJasmijn Hunneman
Jasmijn Hunneman
ADAmalia Dolga
Amalia Dolga
Metabolic reprogramming is a hallmark of the immune cells in response to inflammatory stimuli. This metabolic process involves a switch from oxidative phosphorylation (OXPHOS) to glycolysis or alterations in other metabolic pathways. However, most of the experimental findings have been acquired in murine immune cells, and little is known about the metabolic reprogramming of human microglia. In this study, we investigate the transcriptomic, proteomic, and metabolic profiles of mouse and iPSC-derived human microglia challenged with the TLR4 agonist LPS. We demonstrate that both species display a metabolic shift and an overall increased glycolytic gene signature in response to LPS treatment. The metabolic reprogramming is characterized by the upregulation of hexokinases in mouse microglia and phosphofructokinases in human microglia. This study provides a direct comparison of metabolism between mouse and human microglia, highlighting the species-specific pathways involved in immunometabolism and the importance of considering these differences in translational research.

1 August 2015 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
WSW. Schaafsma
W. Schaafsma
XZX. Zhang
X. Zhang
KZK.C. van Zomeren
K.C. van Zomeren
SJS. Jacobs
S. Jacobs
PGP.B. Georgieva
P.B. Georgieva
BEB.J.L. Eggen
B.J.L. Eggen